Free Trial

National Health Investors, Inc. $NHI Shares Sold by Deutsche Bank AG

National Health Investors logo with Finance background

Key Points

  • Deutsche Bank AG reduced its stake in National Health Investors by 6.9%, now holding approximately 0.24% of the company, valued at about $8.19 million.
  • National Health Investors recently increased its quarterly dividend to $0.92, reflecting a 4.9% yield and a positive change from the previous quarter's dividend of $0.90.
  • Analysts have upgraded the stock's rating, with a consensus recommendation of "Moderate Buy" and a price target of approximately $85.40.
  • Want stock alerts on National Health Investors? Get 5 Weeks of MarketBeat All Access for $5. Get My Stock Alerts.

Deutsche Bank AG cut its holdings in National Health Investors, Inc. (NYSE:NHI - Free Report) by 6.9% during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 110,882 shares of the real estate investment trust's stock after selling 8,197 shares during the period. Deutsche Bank AG owned 0.24% of National Health Investors worth $8,190,000 as of its most recent SEC filing.

Other hedge funds have also modified their holdings of the company. Millennium Management LLC grew its position in National Health Investors by 1,967.0% in the 4th quarter. Millennium Management LLC now owns 488,353 shares of the real estate investment trust's stock valued at $33,843,000 after acquiring an additional 464,727 shares during the last quarter. Balyasny Asset Management L.P. bought a new stake in National Health Investors during the fourth quarter valued at about $23,917,000. Marshall Wace LLP boosted its position in National Health Investors by 161.6% during the fourth quarter. Marshall Wace LLP now owns 551,585 shares of the real estate investment trust's stock valued at $38,225,000 after purchasing an additional 340,712 shares in the last quarter. Land & Buildings Investment Management LLC boosted its holdings in National Health Investors by 109.4% in the fourth quarter. Land & Buildings Investment Management LLC now owns 467,056 shares of the real estate investment trust's stock worth $32,367,000 after acquiring an additional 243,999 shares in the last quarter. Finally, Northern Trust Corp boosted its holdings in National Health Investors by 19.9% in the fourth quarter. Northern Trust Corp now owns 613,791 shares of the real estate investment trust's stock worth $42,536,000 after acquiring an additional 101,808 shares in the last quarter. 62.51% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several brokerages have recently issued reports on NHI. Truist Financial raised their price objective on National Health Investors from $77.00 to $81.00 and gave the stock a "buy" rating in a research note on Friday. KeyCorp raised National Health Investors from a "sector weight" rating to an "overweight" rating and set a $80.00 price objective on the stock in a report on Thursday, July 10th. Finally, Wedbush raised National Health Investors to a "strong-buy" rating in a research note on Wednesday, July 2nd. One analyst has rated the stock with a Strong Buy rating, three have given a Buy rating and one has given a Hold rating to the company. According to data from MarketBeat, National Health Investors presently has a consensus rating of "Buy" and a consensus target price of $85.40.

Get Our Latest Report on NHI

National Health Investors Stock Up 1.4%

Shares of NYSE:NHI traded up $1.0250 on Tuesday, hitting $75.9150. 69,229 shares of the company's stock were exchanged, compared to its average volume of 247,931. The firm's 50-day moving average is $71.61 and its 200 day moving average is $72.34. The company has a market capitalization of $3.60 billion, a PE ratio of 24.25, a P/E/G ratio of 3.75 and a beta of 0.73. National Health Investors, Inc. has a 1-year low of $65.13 and a 1-year high of $86.13. The company has a debt-to-equity ratio of 0.75, a quick ratio of 10.91 and a current ratio of 10.91.

National Health Investors (NYSE:NHI - Get Free Report) last announced its earnings results on Wednesday, August 6th. The real estate investment trust reported $1.22 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.16 by $0.06. The firm had revenue of $70.27 million during the quarter, compared to analysts' expectations of $86.46 million. National Health Investors had a return on equity of 10.32% and a net margin of 40.97%.The business's revenue was up 6.7% on a year-over-year basis. During the same period in the prior year, the firm earned $1.18 EPS. Sell-side analysts predict that National Health Investors, Inc. will post 4.41 EPS for the current year.

National Health Investors Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Tuesday, September 30th will be paid a $0.92 dividend. This represents a $3.68 annualized dividend and a yield of 4.8%. The ex-dividend date of this dividend is Tuesday, September 30th. This is an increase from National Health Investors's previous quarterly dividend of $0.90. National Health Investors's dividend payout ratio (DPR) is 117.57%.

National Health Investors Company Profile

(Free Report)

Incorporated in 1991, National Health Investors, Inc NYSE: NHI is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.

Featured Stories

Institutional Ownership by Quarter for National Health Investors (NYSE:NHI)

Should You Invest $1,000 in National Health Investors Right Now?

Before you consider National Health Investors, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and National Health Investors wasn't on the list.

While National Health Investors currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Follow the Money: 5 Stocks Institutions Are Buying NOW
Palantir’s Soaring Valuation—Justified or Overhyped?
3 Stocks With Explosive Upside

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines